Journal of Applied Physiology Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 83: 25-31, 1997;
8750-7587/97 $5.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colice, G. L.
Right arrow Articles by Ou, L.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colice, G. L.
Right arrow Articles by Ou, L.-C.

Journal of Applied Physiology
Vol. 83, No. 1, pp. 25-31, July 1997
PULMONARY CIRCULATION AND LUNG FLUID BALANCE

Exaggerated pulmonary hypertension with monocrotaline in rats susceptible to chronic mountain sickness

Gene L. Colice, Nicholas Hill, Yan-Jie Lee, Hongkai Du, James Klinger, James C. Leiter, and Lo-Chang Ou

Departments of Medicine and Physiology, Dartmouth Medical School, Lebanon, New Hampshire 03756; and Rhode Island Hospital and Brown University, Providence, Rhode Island 02903

Received 28 May 1996; accepted in final form 24 February 1996.

Colice, Gene L., Nicholas Hill, Yan-Jie Lee, Hongkai Du, James Klinger, James C. Leiter, and Lo-Chang Ou. Exaggerated pulmonary hypertension with monocrotaline in rats susceptible to chronic mountain sickness. J. Appl. Physiol. 83(1): 25-31, 1997.---Hilltop (H) strain Sprague-Dawley rats are more susceptible to chronic mountain sickness than are the Madison (M) strain rats. It is unclear what role pulmonary vascular remodeling, polycythemia, and hypoxia-induced vasoconstriction play in mediating the more severe pulmonary hypertension that develops in the H rats during chronic hypoxia. It is also unclear whether the increased sensitivity of the H rats to chronic mountain sickness is specific for a hypoxia effect or, instead, reflects a general propensity toward the development of pulmonary hypertension. Monocrotaline (MCT) causes pulmonary vascular remodeling and pulmonary hypertension. We hypothesized that the difference in the pulmonary vascular response to chronic hypoxia between H and M rats reflects an increased sensitivity of the H rats to any pulmonary hypertensive stimuli. Consequently, we expected the two strains to also differ in their susceptibility to MCT-induced pulmonary hypertension. Pulmonary arterial pressures in conscious H and M rats were measured 3 wk after a single dose of MCT, exposure to a simulated high altitude of 18,000 ft (barometric pressure = 380 mmHg), and administration of a single dose of saline as a placebo. The H rats had significantly higher pulmonary arterial pressures and right ventricular weights after MCT and chronic hypoxia than did the M rats. The H rats also had more pulmonary vascular remodeling, i.e., greater wall thickness as a percentage of vessel diameter, after MCT and chronic hypoxia than did the M rats. The H rats had significantly lower arterial PO2 than did the M rats after MCT, but the degree of hypoxemia was mild [arterial PO2 of 72.5 ± 0.8 (SE) Torr for H rats vs. 77.4 ± 0.8 Torr for M rats after MCT]. The H rats had lower arterial PCO2 and larger minute ventilation values than did the M rats after MCT. These ventilatory differences suggest that MCT caused more severe pulmonary vascular damage in the H rats than in the M rats. These data support the hypothesis that the H rats have a general propensity to develop pulmonary hypertension and suggest that differences in pulmonary vascular remodeling account for the increased susceptibility of H rats, compared with M rats, to both MCT and chronic hypoxia-induced pulmonary hypertension.

chronic hypoxia; ventilation; pulmonary vascular histology


0161-7567/97 $5.00 Copyright © 1997 the American Physiological Society




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
F. Akhavein, E. J. St.-Michel, E. Seifert, and C. V. Rohlicek
Decreased left ventricular function, myocarditis, and coronary arteriolar medial thickening following monocrotaline administration in adult rats
J Appl Physiol, July 1, 2007; 103(1): 287 - 295.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. E. van Albada, R. G. Schoemaker, M. S. Kemna, A. H. Cromme-Dijkhuis, R. van Veghel, and R. M. F. Berger
The role of increased pulmonary blood flow in pulmonary arterial hypertension
Eur. Respir. J., September 1, 2005; 26(3): 487 - 493.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. Salameh, M. R. Karamsetty, R. R. Warburton, J. R. Klinger, L. C. Ou, and N. S. Hill
Differences in acute hypoxic pulmonary vasoresponsiveness between rat strains: role of endothelium
J Appl Physiol, July 1, 1999; 87(1): 356 - 362.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. C. Ou, S. Salceda, S. J. Schuster, L. M. Dunnack, T. Brink-Johnsen, J. Chen, and J. C. Leiter
Polycythemic responses to hypoxia: molecular and genetic mechanisms of chronic mountain sickness
J Appl Physiol, April 1, 1998; 84(4): 1242 - 1251.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. A. QUINN, H.-K. DU, B. TAYLOR THOMPSON, and C. A. HALES
Amiloride Analogs Inhibit Chronic Hypoxic Pulmonary Hypertension
Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1263 - 1268.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online